Articles

Poll

Podcasts

Slideshows

Videos

David G. Armstrong, DPM, PhD, and Michael S. Conte, MD discuss Phase 2 results on anatomically directed lower extremity gene therapy for ulcer healing.

AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD

An IV infusion of exenatide during cardiac surgeries involving bypass did not significantly benefit mortality or organ injury compared with placebo.

GLORIOUS: Exenatide Lacks Preventive Effect on Organ Injury in Cardiac Surgery

AHN’s minimally invasive spine surgery relieves patients’ pain and quickly gets them back to living. 

One-day Decompression at Allegheny Health Network

The approval to GE Healthcare's cyclotron-produced radioactive diagnostic drug provides another option to adequately identify significant coronary artery disease.

FDA Approves Flurpiridaz F 18 Diagnostic Drug for Coronary Artery Disease

The STOP-or-NOT trial found similar outcomes for continuation or discontinuation of RAS inhibitors before noncardiac surgery, supporting individualized decision-making.

STOP-or-NOT: No Benefit to Discontinuing RASi Prior to Major Surgery 

A retrospective study challenges preoperative withholding of GLP-1 RAs in diabetes patients undergoing surgery, citing no increased risk of postoperative respiratory complications.

GLP-1 Receptor Agonists Not Linked to Post-Op Respiratory Complications

Clobetasol propionate ophthalmic suspension 0.05% for post-ocular surgery pain marks the first new steroid in the ophthalmic market in over 15 years.

FDA Approves Clobetasol Propionate Eye Drop for Post-Ocular Surgery Pain

A real-world analysis in the United States suggests hospital volume may not be the lone predictor of outcomes in pediatric cardiac surgery.

Pediatric Cardiac Surgery Outcomes Not Linked to Procedure Volume

Lassailly discusses the role of bariatric surgery versus weight-loss treatments like semaglutide for patients with MASH.

Guillaume Lassailly: How Do We Value Bariatric Surgery in 2023?

The study author discusses the impact of findings showing MASH resolution without worsening fibrosis is a surrogate endpoint for 15-year bariatric surgery survival.

Guillaume Lassailly: The Role of MASH, Fibrosis in Bariatric Surgery Survival

Plastic surgery

The HCPLive plastic surgery page is a comprehensive resource for clinical news and insights on cosmetic and clinic surgery. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for plastic surgery, and more.

The HCPLive surgery page is a resource for medical news and expert insights on invasive medicine. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for surgery, and more.